MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Stoke Therapeutics, Inc. (STOK)

Stoke Therapeutics, Inc. (STOK)

|||

Balance Sheets Overview

Current Ratio
769.23%
Quick Ratio
769.23%
Cash Ratio
262.35%
Debt to Asset Ratio
12.29%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities - current
    • Cash and cash equivalents
    • Marketable securities - long-ter...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Deferred revenue - current porti...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
110,004
155,659
84,220
83,394
Marketable securities - current
182,814
187,886
200,450
164,916
Accounts receivable
7,179
4,451
5,936
9,248
Prepaid expenses
14,688
10,115
8,736
7,747
Restricted cash - short term
-
-
494
0
Interest receivable
1,540
1,690
1,969
1,589
Other current assets
6,313
6,880
3,895
5,543
Total current assets
322,538
366,681
305,700
272,437
Marketable securities - long-term
61,502
67,481
106,260
80,315
Property, and equipment, gross
-
-
13,292
-
Restricted cash - long-term
3,227
3,227
227
721
Less accumulated depreciation
-
-
10,146
-
Operating right-of-use assets
1,870
2,493
3,101
3,708
Property and equipment, net
4,829
3,395
3,146
3,083
Total assets
393,966
443,277
418,434
360,264
Accounts payable
4,794
6,839
4,939
5,871
Accrued and other current liabilities
28,613
23,901
41,035
30,093
Deferred revenue - current portion
8,523
10,066
11,901
5,763
Total current liabilities
41,930
40,806
57,875
41,727
Deferred revenue - net of current portion
5,652
6,603
6,961
8,558
Other long-term liabilities
837
991
1,141
1,874
Total long-term liabilities
6,489
7,594
8,102
10,432
Total liabilities
48,419
48,400
65,977
52,159
Common stock, par value of 0.0001 per share 300,000,000 shares authorized, 62,402,595 and 58,921,999 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
6
6
5
5
Additional paid-in capital
955,419
942,704
849,624
747,435
Accumulated other comprehensive (loss) income
-542
-115
543
446
Accumulated deficit
-609,336
-547,718
-497,715
-439,781
Total stockholders equity
345,547
394,877
352,457
308,105
Total liabilities and stockholders equity
393,966
443,277
418,434
360,264
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities -current$182,814K (25.01%↑ Y/Y)Cash and cashequivalents$110,004K (8.41%↑ Y/Y)Prepaid expenses$14,688K (7.26%↑ Y/Y)Accounts receivable$7,179K Other current assets$6,313K (-8.12%↓ Y/Y)Interest receivable$1,540K (-5.06%↓ Y/Y)Total current assets$322,538K (19.47%↑ Y/Y)Marketable securities -long-term$61,502K (-42.66%↓ Y/Y)Property and equipment,net$4,829K (44.45%↑ Y/Y)Restricted cash - long-term$3,227K (347.57%↑ Y/Y)Operating right-of-useassets$1,870K (-41.89%↓ Y/Y)Total assets$393,966K (2.46%↑ Y/Y)Total liabilities andstockholders equity$393,966K (2.46%↑ Y/Y)Total stockholdersequity$345,547K (3.17%↑ Y/Y)Total liabilities$48,419K (-2.31%↓ Y/Y)Accumulated deficit-$609,336K (-51.79%↓ Y/Y)Accumulated othercomprehensive (loss) income-$542K (-664.58%↓ Y/Y)Additional paid-in capital$955,419K (29.76%↑ Y/Y)Total currentliabilities$41,930K (8.41%↑ Y/Y)Total long-termliabilities$6,489K (-40.40%↓ Y/Y)Common stock, par valueof 0.0001 per share...$6K (20.00%↑ Y/Y)Accrued and othercurrent liabilities$28,613K (11.70%↑ Y/Y)Deferred revenue -current portion$8,523K (-2.58%↓ Y/Y)Accounts payable$4,794K (11.15%↑ Y/Y)Deferred revenue - net ofcurrent portion$5,652K (-41.32%↓ Y/Y)Other long-termliabilities$837K (-33.31%↓ Y/Y)